NO20065657L - Filmformet ostriol-inneholdende medikament for oral administrasjon - Google Patents

Filmformet ostriol-inneholdende medikament for oral administrasjon

Info

Publication number
NO20065657L
NO20065657L NO20065657A NO20065657A NO20065657L NO 20065657 L NO20065657 L NO 20065657L NO 20065657 A NO20065657 A NO 20065657A NO 20065657 A NO20065657 A NO 20065657A NO 20065657 L NO20065657 L NO 20065657L
Authority
NO
Norway
Prior art keywords
film
shaped
ostriol
oral administration
containing drug
Prior art date
Application number
NO20065657A
Other languages
English (en)
Norwegian (no)
Inventor
Walter Elger
Joachim Moormann
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20065657L publication Critical patent/NO20065657L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20065657A 2004-05-14 2006-12-07 Filmformet ostriol-inneholdende medikament for oral administrasjon NO20065657L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004023984A DE102004023984A1 (de) 2004-05-14 2004-05-14 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
PCT/EP2005/004894 WO2005110358A2 (fr) 2004-05-14 2005-05-06 Agent pharmaceutique a administration orale, en forme de film, contenant de l'oestriol

Publications (1)

Publication Number Publication Date
NO20065657L true NO20065657L (no) 2006-12-07

Family

ID=34977101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065657A NO20065657L (no) 2004-05-14 2006-12-07 Filmformet ostriol-inneholdende medikament for oral administrasjon

Country Status (16)

Country Link
US (1) US20070243217A1 (fr)
EP (1) EP1761242A2 (fr)
JP (1) JP2007537178A (fr)
KR (1) KR20070040753A (fr)
CN (1) CN1997349A (fr)
AR (1) AR048958A1 (fr)
AU (1) AU2005244409A1 (fr)
BR (1) BRPI0510855A (fr)
CA (1) CA2566325A1 (fr)
DE (1) DE102004023984A1 (fr)
IL (1) IL179014A0 (fr)
MX (1) MXPA06012890A (fr)
NO (1) NO20065657L (fr)
RU (1) RU2006140649A (fr)
TW (1) TW200536547A (fr)
WO (1) WO2005110358A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
WO2009101021A2 (fr) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Système d'administration de médicament contenant de l'estradiol
WO2009132208A1 (fr) * 2008-04-24 2009-10-29 Evestra, Inc. Formes galéniques contraceptives orales renfermant un progestogène dispersé dans un polymère gastrorésistant et renfermant en outre un œstrogène
US20110250274A1 (en) * 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
KR102044515B1 (ko) * 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO301689B1 (no) * 1987-09-24 1997-12-01 Jencap Research Ltd Kontraseptivt preparat i form av en forpakning
ES2123666T3 (es) * 1992-03-21 1999-01-16 Entec Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny

Also Published As

Publication number Publication date
WO2005110358A3 (fr) 2007-03-15
DE102004023984A1 (de) 2005-12-08
BRPI0510855A (pt) 2007-12-26
TW200536547A (en) 2005-11-16
MXPA06012890A (es) 2007-07-19
CN1997349A (zh) 2007-07-11
AR048958A1 (es) 2006-06-14
JP2007537178A (ja) 2007-12-20
AU2005244409A1 (en) 2005-11-24
CA2566325A1 (fr) 2005-11-24
RU2006140649A (ru) 2008-05-27
US20070243217A1 (en) 2007-10-18
EP1761242A2 (fr) 2007-03-14
IL179014A0 (en) 2007-03-08
KR20070040753A (ko) 2007-04-17
WO2005110358A2 (fr) 2005-11-24

Similar Documents

Publication Publication Date Title
EP2444072A3 (fr) Formes galéniques de film non mucoadhésifs
PE20040134A1 (es) Forma de dosificacion de una vez al dia de pramipexol
WO2008142572A3 (fr) Formulation de comprimé à libération contrôlée contenant de l'aluminométasilicate de magnésium
NO20065657L (no) Filmformet ostriol-inneholdende medikament for oral administrasjon
WO2005065069A3 (fr) Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
CR7654A (es) Una combinacion de azelatina y esteroides
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
WO2002043765A3 (fr) Formulations pharmaceutiques contenant du paclitaxel, ses derives et ses sels pharmaceutiquement acceptables
JP2014528474A5 (fr)
WO2006113505A3 (fr) Systemes d'apport de substances pharmaceutiques destines a des medicaments hydrophobes et compositions comprenant ces derniers
JP2006508953A5 (fr)
EP2216024A3 (fr) Utilisation de ranolazine pour le traitement de maladies cardiovasculaires
JP2009517411A5 (fr)
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
NO20044496L (no) Torr pulver innhaleringssammensetning
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
WO2007086079A3 (fr) Forme de dose a liberation soutenue de derives de phenothiazine contenant un canalisateur
BRPI0520797B8 (pt) forma de dosagem farmacêutica comprimida em bicamadas
EP1778209B8 (fr) Methodes et compositions d'administration orale de fts
JP2011500589A5 (fr)
WO2005120518A3 (fr) Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires